AlphaCentric Advisors’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$39K Sell
563
-28
-5% -$2.69K 0.04% 197
2024
Q3
$80.4K Sell
591
-20
-3% -$2.63K 0.06% 207
2024
Q2
$82.4K Sell
611
-22
-3% -$3.36K 0.06% 183
2024
Q1
$109K Sell
633
-84
-12% -$12.8K 0.07% 183
2023
Q4
$111K Buy
+717
New +$93.5K 0.07% 158
2021
Q4
$137K Sell
813
-149
-15% -$24.3K 0.04% 144
2021
Q3
$145K Buy
962
+1
+0.1% +$154 0.04% 139
2021
Q2
$146K Buy
+961
New +$153K 0.04% 141

Other funds holding CE

AlphaCentric Advisors's CE Position: Q4 2024 in Review

AlphaCentric Advisors reduced its Celanese (CE) stake by 4.7% in Q4 2024, selling an estimated $2.69K and leaving 563 shares worth $39K. The position accounts for 0.04% of the portfolio, ranked #197.

AlphaCentric Advisors first reported a position in CE in Q2 2021 and has held it in 8 quarters since. The position peaked at $146K in Q2 2021. 569 funds tracked by Wall St. Rank hold CE as of Q4 2024.

  • AlphaCentric Advisors held 563 shares of Celanese worth $39K as of Q4 2024.
  • AlphaCentric Advisors sold 28 Celanese shares in Q4 2024, an estimated $2.69K.
  • Celanese made up 0.04% of AlphaCentric Advisors's portfolio in Q4 2024, its #197 holding.
  • AlphaCentric Advisors first reported a position in Celanese in Q2 2021 and has held it in 8 quarters since.
  • AlphaCentric Advisors's Celanese position peaked at $146K in Q2 2021.
  • 569 funds tracked by Wall St. Rank held Celanese as of Q4 2024.

Based on AlphaCentric Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.